Furthermore, autoantibody-positive non-RA patients frequently became negative in the second sample (9% for ACPA and 17% for IgM-RF, respectively), whereas autoantibody-negative non-RA patients seldom became positive (Figure 1). This evidence concerns the gene CD40LG and rheumatoid arthritis.